iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve Patients PHASE 3 Study
 
 
  This study is not yet open for participant recruitment.
Verified by Novartis, March 2011
First Received: March 17, 2011

Ame.gif

http://clinicaltrials.gov/ct2/show/NCT01318694?term=alisporivir&rank=1
 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org